Tofacitinib CAS:477600-75-2 Mugadziri Mutengesi
Tofacitinib mushonga wekurapa rheumatoid arthritis (RA), psoriasis, inflammatory bowel chirwere, uye zvimwe zvirwere zveimmunological, pamwe nekudzivirira kurambwa kwenhengo.Iyo inhibitor ye enzyme Janus kinase 3 (JAK3), zvinoreva kuti inovhiringa nzira yekusaina yeJAK-STAT inotumira ruzivo kunze kwesero mukati mesero nucleus, ichipesvedzera kunyorwa kweDNA.Munguva pfupi yapfuura yakaratidzwa mumurine muenzaniso weArthritis yakasimbiswa, tofacitinib yakakurumidza kuvandudzwa chirwere nekudzivisa kugadzirwa kwevamiririri vanopisa uye kudzvinyirira STAT1-inotsamira majini muhutano hwekubatana.Kubudirira uku mumuenzaniso wechirwere ichi kwakabatana nekudzivisa kwezvose JAK1 uye 3 chiratidzo. nzira, zvichiratidza kuti tofacitinib inogona kushandisa rubatsiro rwekurapa kuburikidza nenzira dzisiri dzega kuvharisa kweJAK3.
 
 		     			 
 		     			 
 		     			| Composition | C16H20N6O | 
| Assay | 99% | 
| Chitarisiko | Off-white powder | 
| CAS Nha. | 477600-75-2 | 
| Packing | 25KG | 
| Sherufu Hupenyu | 2 years | 
| Storage | Chengetedza munzvimbo inotonhorera uye yakaoma | 
| Certification | ISO. | 
 
 				







